Yes Bank's board approves fund-raising plan of ₹16,000 crore and AoA changes as part of its agreement with Sumitomo Mitsui ...

Indian Rupee opened lower for the second straight day on Tuesday amid renewed foreign outflows and a recovery in the dollar ...

Alphabet is set to invest $500 million over 10 years to overhaul its compliance structure under a shareholder lawsuit ...

South Korea's stocks and its currency surged as liberal presidential candidate Lee Jae-myung's election victory raised hopes ...

In one incident, forces struck a Hamas operative positioned near a weapons depot, triggering secondary explosions that ...

PNB has cut interest rates on its Vidyalaxmi education loans by 20 basis points, bringing down rates from 7.7% to 7.5% ...

Brazil's President Luiz Incio Lula da Silva on Tuesday signed a new law to expand the country's affirmative action policies, ...

South Korea led regional gains as markets reopened following the presidential election victory of opposition leader Lee ...

Quick Routes International on Tuesday exited Zinka Logistics Solutions by selling a 9 per cent stake in the company for Rs ...

The Trump administration announced on Tuesday that it would revoke guidance to the nation's hospitals that directed them to ...

Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Angiotensin II Acetate Injection 2.5 mg/mL.

Zydus Lifesciences wholly owned subsdiary, Zynext Ventures, has entered into share purchase agreement with Aegnus, USA to acquire 5.9% stake for a total consideration of $16 million. Ashok Leyland ...